CVE:LXG LexaGene (LXG) Stock Price, News & Analysis C$0.10 -0.03 (-19.23%) As of 02/21/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About LexaGene Stock (CVE:LXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LexaGene alerts:Sign Up Key Stats Today's RangeC$0.10▼C$0.1450-Day RangeC$0.11▼C$0.1152-Week RangeC$0.07▼C$0.31Volume2.14 million shsAverage Volume170,061 shsMarket CapitalizationC$14.77 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewLexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.Read More… Remove Ads Receive LXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter. Email Address LXG Stock News HeadlinesPamapol Ord Share Price (0LXG)April 9, 2024 | lse.co.ukBiosynex SA ALBIONovember 12, 2023 | morningstar.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 1, 2025 | Porter & Company (Ad)Cyclopharm Ltd CYCOctober 31, 2023 | morningstar.comLexagene Holdings Inc (LXGh)October 16, 2023 | investing.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliSeptember 2, 2023 | morningstar.comZhejiang Gongdong Medical Technology Co Ltd Class AJuly 28, 2023 | morningstar.comIIROC Trading Halt - LXGFebruary 22, 2023 | finance.yahoo.comSee More Headlines LXG Stock Analysis - Frequently Asked Questions How have LXG shares performed this year? LexaGene's stock was trading at C$0.11 at the start of the year. Since then, LXG stock has increased by 0.0% and is now trading at C$0.11. View the best growth stocks for 2025 here. How do I buy shares of LexaGene? Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of LexaGene own? Based on aggregate information from My MarketBeat watchlists, some other companies that LexaGene investors own include Citius Pharmaceuticals (CTXR), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Athersys (ATHX), Bionano Genomics (BNGO), EQT (EQT) and Inovio Pharmaceuticals (INO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCVE:LXG CIKN/A Webwww.lexagene.com Phone800-215-1824FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-8,540,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-339.54% Return on Assets-120.21% Debt Debt-to-Equity Ratio138.01 Current Ratio1.39 Quick Ratio1.13 Sales & Book Value Annual SalesC$110,927.00 Price / Sales133.13 Cash FlowC$0.00 per share Price / Cash Flow21.25 Book ValueC$0.01 per share Price / Book10.50Miscellaneous Outstanding Shares140,640,000Free FloatN/AMarket CapC$14.77 million OptionableNot Optionable Beta2.26 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (CVE:LXG) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LexaGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.